From: Effect of a standardized treatment regime for infection after osteosynthesis
Microorganism | Cases (n = 49) | Primary success rate (%) | Overall success rate (%) | Antimicrobial susceptibilitya (%) | |
---|---|---|---|---|---|
Rifampicin | Vancomycin | ||||
No growth | 5 (10%) | 80 | 80 | – | – |
Staphylococcus aureus | 16 (33%) | 63 | 88 | 100 | 100 |
MSSA | 15 (94%) | ||||
MRSA | 1 (6%) | ||||
Coagulase-negative staphylococci | 2 (4%) | 50 | 100 | 100 | 100 |
Polymicrobial infectionsb | 21 (43%) | 52 | 86 | 86 | 91 |
Other single microbial infectionsc | 4 (8%) | 100 | 100 | 25 | 50 |
Rifampicin resistance at first culture | 3 (6%) | Overall susceptibility | 88 | 91 |